Westchester Capital Management (Nebraska)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-75
| Closed | -$5.4K | – | 47 |
|
|
2022
Q4 | $5.4K | Hold |
75
| – | – | ﹤0.01% | 44 |
|
|
2022
Q3 | $5K | Hold |
75
| – | – | ﹤0.01% | 46 |
|
|
2022
Q2 | $6K | Hold |
75
| – | – | ﹤0.01% | 48 |
|
|
2022
Q1 | $5K | Hold |
75
| – | – | ﹤0.01% | 46 |
|
|
2021
Q4 | $5K | Hold |
75
| – | – | ﹤0.01% | 44 |
|
|
2021
Q3 | $4K | Hold |
75
| – | – | ﹤0.01% | 46 |
|
|
2021
Q2 | $5K | Hold |
75
| – | – | ﹤0.01% | 43 |
|
|
2021
Q1 | $5K | Buy |
+75
| New | +$5K | ﹤0.01% | 46 |
|
|
2020
Q2 | – | Sell |
-587
| Closed | -$33K | – | 42 |
|
|
2020
Q1 | $33K | Hold |
587
| – | – | 0.01% | 37 |
|
|
2019
Q4 | $38K | Buy |
+587
| New | +$38K | 0.01% | 38 |
|